The janus face of immunosuppression – de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

Markus Guba, Philipp von Breitenbuch, Markus Steinbauer et al. · Nature Medicine · 2002 · 1.7K citations

Medicine, Oncology, Pharmacology +16

Cancer after Kidney Transplantation in the United States

Bertram L. Kasiske, Jon J. Snyder, David T. Gilbertson et al. · American Journal of Transplantation · 2004 · 1.1K citations

Medicine, Oncology, Surgery +14

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

Patrick Maisonneuve, Lawrence Y. Agodoa, Ryszard Gellert et al. · The Lancet · 1999 · 879 citations

Medicine, Nephrology, Oncology +14

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

Jacques Dantal, Maryvonne Hourmant, Diego Cantarovich et al. · The Lancet · 1998 · 747 citations

Medicine, Immunology, Oncology +15

Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage

Peter O’Donovan, Conal M. Perrett, Xiaohong Zhang et al. · Science · 2005 · 631 citations · Full text

Medicine, Dermatology, Oncology +16